Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 11 studies | 58% ± 24% | |
oligodendrocyte precursor cell | 11 studies | 26% ± 7% | |
oligodendrocyte | 9 studies | 24% ± 10% | |
GABAergic neuron | 8 studies | 38% ± 19% | |
neuron | 6 studies | 34% ± 9% | |
interneuron | 6 studies | 40% ± 13% | |
endothelial cell | 4 studies | 34% ± 17% | |
GABAergic interneuron | 3 studies | 23% ± 5% | |
granule cell | 3 studies | 32% ± 15% | |
precursor B cell | 3 studies | 40% ± 10% | |
retina horizontal cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 14 studies | 35% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 7477.55 | 2611 / 2642 | 100% | 83.06 | 702 / 705 |
ovary | 100% | 2634.82 | 180 / 180 | 92% | 24.51 | 394 / 430 |
adrenal gland | 91% | 865.64 | 236 / 258 | 94% | 41.97 | 216 / 230 |
uterus | 98% | 1460.06 | 166 / 170 | 86% | 27.73 | 396 / 459 |
esophagus | 97% | 1310.84 | 1405 / 1445 | 80% | 17.78 | 146 / 183 |
breast | 91% | 996.79 | 417 / 459 | 68% | 11.33 | 760 / 1118 |
prostate | 73% | 648.48 | 178 / 245 | 84% | 10.57 | 422 / 502 |
kidney | 70% | 684.15 | 62 / 89 | 87% | 16.25 | 783 / 901 |
skin | 79% | 1224.54 | 1422 / 1809 | 77% | 13.55 | 363 / 472 |
bladder | 86% | 772.81 | 18 / 21 | 66% | 11.75 | 333 / 504 |
lung | 59% | 469.73 | 340 / 578 | 73% | 19.39 | 840 / 1155 |
intestine | 75% | 1162.36 | 720 / 966 | 46% | 5.51 | 245 / 527 |
thymus | 44% | 330.03 | 285 / 653 | 55% | 5.99 | 330 / 605 |
adipose | 92% | 1020.18 | 1113 / 1204 | 0% | 0 | 0 / 0 |
liver | 41% | 281.74 | 92 / 226 | 51% | 7.38 | 207 / 406 |
tonsil | 0% | 0 | 0 / 0 | 84% | 15.95 | 38 / 45 |
pancreas | 13% | 88.76 | 41 / 328 | 71% | 9.52 | 126 / 178 |
stomach | 38% | 843.50 | 138 / 359 | 44% | 6.48 | 125 / 286 |
blood vessel | 79% | 752.66 | 1051 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 45% | 4.37 | 36 / 80 |
lymph node | 0% | 0 | 0 / 0 | 21% | 2.32 | 6 / 29 |
heart | 8% | 58.99 | 73 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 8% | 76.78 | 74 / 929 | 0% | 0 | 0 / 0 |
spleen | 6% | 41.55 | 15 / 241 | 0% | 0 | 0 / 0 |
muscle | 1% | 9.14 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0072673 | Biological process | lamellipodium morphogenesis |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_1990416 | Biological process | cellular response to brain-derived neurotrophic factor stimulus |
GO_0097484 | Biological process | dendrite extension |
GO_0051388 | Biological process | positive regulation of neurotrophin TRK receptor signaling pathway |
GO_0030041 | Biological process | actin filament polymerization |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0007005 | Biological process | mitochondrion organization |
GO_0098885 | Biological process | modification of postsynaptic actin cytoskeleton |
GO_0016601 | Biological process | Rac protein signal transduction |
GO_2000601 | Biological process | positive regulation of Arp2/3 complex-mediated actin nucleation |
GO_0005856 | Cellular component | cytoskeleton |
GO_0032991 | Cellular component | protein-containing complex |
GO_0098794 | Cellular component | postsynapse |
GO_0005925 | Cellular component | focal adhesion |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0030027 | Cellular component | lamellipodium |
GO_0031209 | Cellular component | SCAR complex |
GO_0034237 | Molecular function | protein kinase A regulatory subunit binding |
GO_0071933 | Molecular function | Arp2/3 complex binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0051018 | Molecular function | protein kinase A binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | WASF1 |
Protein name | WASP family member 1 Actin-binding protein WASF1 (Protein WAVE-1) (Verprolin homology domain-containing protein 1) (Wiskott-Aldrich syndrome protein family member 1) (WASP family protein member 1) |
Synonyms | KIAA0269 SCAR1 WAVE1 |
Description | FUNCTION: Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation . The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex (By similarity). As component of the WAVE1 complex, required for BDNF-NTRK2 endocytic trafficking and signaling from early endosomes (By similarity). Also involved in the regulation of mitochondrial dynamics . . |
Accessions | ENST00000392586.5 Q92558 ENST00000392589.6 Q5SZK3 ENST00000368938.5 ENST00000447287.5 ENST00000359451.6 ENST00000444391.5 Q5SZK5 ENST00000392588.5 Q5SZK4 ENST00000265601.7 ENST00000419252.1 ENST00000392587.6 |